Health News Archive - April 26, 2012
NANJING, China, April 26, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development,
HASSELT, Belgium, April 26, 2012 /PRNewswire/ -- Alphabodies cross over the boundaries between biologics and small chemical drugs Complix NV, a biopharmaceutical
SILVER SPRING, Md., April 26, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2012. "I
SCHAFFHAUSEN, Switzerland, April 26, 2012 /PRNewswire/ -- Company reports second quarter revenue of $4.4 billion, with 9% revenue growth and 7% organic growth Operating
PHILADELPHIA, April 26, 2012 /PRNewswire/ -- Shire plc [http://www.shire.com/shireplc/en/home ] (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company,
PARSIPPANY, New Jersey, April 26, 2012 /PRNewswire/ -- - Creates 3rd largest global generics company - - ~$8.0 billion anticipated pro forma combined
-- On March 17(th) at the American Academy of Dermatology Annual Meeting, ZO Skin Health, Inc. introduced its new line of medical skin care products, ZO® MEDICAL
